PentaBind
PentaBind designs high-performance aptamers to accelerate therapeutic and diagnostic development with fewer experimental iterations. The company combines generative AI and machine learning models with an integrated wet-laboratory platform and laboratory automation to design aptamers with multiple drug-like qualities in a single step, reducing reliance on traditional SELEX screening. Its technology stack centers on Generative AI, AI-driven design, SELEX-informed workflows, and lab automation, and the company operates as a hybrid B2B SaaS and services provider while also advancing its own pipeline assets. Target customers include biotechnology companies and pharmaceutical researchers pursuing precision therapeutics and targeted delivery applications.
PentaBind
PentaBind designs high-performance aptamers to accelerate therapeutic and diagnostic development with fewer experimental iterations. The company combines generative AI and machine learning models with an integrated wet-laboratory platform and laboratory automation to design aptamers with multiple drug-like qualities in a single step, reducing reliance on traditional SELEX screening. Its technology stack centers on Generative AI, AI-driven design, SELEX-informed workflows, and lab automation, and the company operates as a hybrid B2B SaaS and services provider while also advancing its own pipeline assets. Target customers include biotechnology companies and pharmaceutical researchers pursuing precision therapeutics and targeted delivery applications.
